Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Hematologic Oncology Update
00:00
Future of CELMoDs Versus Lenalidomide
Matt considers CELMoDs as more potent cereblon modulators and their potential to replace lenalidomide across lymphoma settings.
Play episode from 48:46
Transcript
